Get started
Author

Bjoern Traenkle

SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
2020 · Annika Nelde, Tatjana Bilich, et al. · Nature Immunology · 611
PDF
A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging
2018 · David Virant, Bjoern Traenkle, et al. · Nature Communications · 167
PDF
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
2021 · Matthias Becker, Alex Dulovic, et al. · Nature Communications · 142
PDF
Peptides in headlock – a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy
2016 · Michael B. Braun, Bjoern Traenkle, et al. · Scientific Reports · 123
PDF
Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
2017 · Bjoern Traenkle, Ulrich Rothbauer · Frontiers in Immunology · 119
PDF
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
2021 · Matthias Becker, Monika Strengert, et al. · Nature Communications · 85
PDF
Robust and durable serological response following pediatric SARS-CoV-2 infection
2022 · Hanna Renk, Alex Dulovic, et al. · Nature Communications · 84
PDF
Monitoring Interactions and Dynamics of Endogenous Beta-catenin With Intracellular Nanobodies in Living Cells*
2015 · Bjoern Traenkle, Felix Emele, et al. · Molecular & Cellular Proteomics · 82
PDF
Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies
2015 · Julia Maier, Bjoern Traenkle, et al. · Scientific Reports · 80
PDF
Recent progress in generating intracellular functional antibody fragments to target and trace cellular components in living cells
2014 · Philipp D. Kaiser, Julia Maier, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 79
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis
2021 · Monika Strengert, Matthias Becker, et al. · EBioMedicine · 70
PDF
NeutrobodyPlex—monitoring SARS-CoV-2 neutralizing immune responses using nanobodies
2021 · Teresa R. Wagner, Philipp D. Kaiser, et al. · EMBO Reports · 50
PDF
Single-Domain Antibodies for Targeting, Detection, and In Vivo Imaging of Human CD4+ Cells
2021 · Bjoern Traenkle, Philipp D. Kaiser, et al. · Frontiers in Immunology · 43
PDF
A novel epitope tagging system to visualize and monitor antigens in live cells with chromobodies
2020 · Bjoern Traenkle, Sören Segan, et al. · Scientific Reports · 42
PDF
Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors
2021 · Martin V. Hamann, Niklas Beschorner, et al. · PLoS ONE · 39
PDF
Chromobodies to Quantify Changes of Endogenous Protein Concentration in Living Cells
2018 · Bettina-Maria Keller, Julia Maier, et al. · Molecular & Cellular Proteomics · 34
Visualizing Epithelial–Mesenchymal Transition Using the Chromobody Technology
2016 · Julia Maier, Bjoern Traenkle, et al. · Cancer Research · 30
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
2021 · Teresa R. Wagner, Daniel Schnepf, et al. · EMBO Reports · 27
PDF
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
2022 · Daniel Junker, Alex Dulovic, et al. · Scientific Reports · 26
PDF
Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
2022 · Alex Dulovic, Monika Strengert, et al. · Emerging infectious diseases · 25
PDF
A Strategy to Optimize the Generation of Stable Chromobody Cell Lines for Visualization and Quantification of Endogenous Proteins in Living Cells
2019 · Bettina-Maria Keller, Julia Maier, et al. · Antibodies · 23
PDF
A Multiplexed High-Content Screening Approach Using the Chromobody Technology to Identify Cell Cycle Modulators in Living Cells
2016 · Kenji Schorpp, Ina Rothenaigner, et al. · SLAS DISCOVERY · 23
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
2022 · Matthias Becker, Anne Cossmann, et al. · Frontiers in Immunology · 18
PDF
Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
2022 · Daniel Junker, Matthias Becker, et al. · Clinical Infectious Diseases · 18
PDF
A Novel PNGase Rc for Improved Protein N-Deglycosylation in Bioanalytics and Hydrogen–Deuterium Exchange Coupled With Mass Spectrometry Epitope Mapping under Challenging Conditions
2022 · Marius Gramlich, Sandra Maier, et al. · Analytical Chemistry · 16
PDF
Works count: 38
Citation count: 2,133
H-index: 22
I10-index: 29
Year
Topic
Type